- F.D.A. Delays Action on Closely Watched Alzheimer’s Drug (nytimes.com)
- Midlife belly fat linked to Alzheimer’s disease decades later: study (nydailynews.com)
- Internal review found ‘falsified data’ in Stanford President’s Alzheimer’s research, colleagues allege (stanforddaily.com)
- Alzheimer’s drug lecanemab hailed as momentous breakthrough (bbc.com)